{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:38:40Z","timestamp":1771922320226,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In neurological disorders associated with autoantibodies against intracellular antigens, response to therapy tends to be poor and is associated with irreversible neuronal death. This study aimed to analyze autoimmune encephalitis (AE) associated with antibodies (Abs) against intracellular antigens in children, clarify the clinical characteristics of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed patients with Abs against intracellular antigens at Qilu Hospital of Shandong University from 2024 to 2025. Detailed clinical characteristics were collected based on AE-Abs test results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen pediatric patients with AE caused by intracellular Abs were recruited. The Abs included PCA-2, AGO, GFAP, SOX1, Ri, Yo, KLHL11, and AK5. All the patients received immunotherapy. After treatment, the antibody titers in the cerebrospinal fluid and serum of patients mostly decreased or even turned negative. Some patients were discharged with sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In AE associated with Abs against intracellular antigens of children, seizures were the most common clinical manifestation. For patients with seizures without obvious inducement or suspected encephalitis, AE-related Abs should be detected promptly, and immunosuppressive therapy should be administered as early as possible. The prognosis of pediatric patients with encephalitis with Abs differs from that in adults, and most patients recover well after active treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1678497","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:21:20Z","timestamp":1768540880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune encephalitis associated with antibodies against intracellular antigens in children"],"prefix":"10.3389","volume":"16","author":[{"given":"Linlin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Qilu Hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Che","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Qilu Hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Qilu Hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihua","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Qilu Hospital of Shandong University","place":["Jinan, Shandong, China"]},{"name":"Department of Pediatrics, Qilu Hospital of Shandong University Dezhou Hospital","place":["Dezhou, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"577601","DOI":"10.1016\/j.jneuroim.2021.577601","article-title":"Assessing the role of a tissue-based assay in the diagnostic algorithm of autoimmune encephalitis","volume":"356","author":"Masi","year":"2021","journal-title":"J Neuroimmunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pediatrneurol.2016.04.004","article-title":"Antibody-mediated autoimmune encephalitis in childhood","volume":"60","author":"Brenton","year":"2016","journal-title":"Pediatr Neurology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens\u2013pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812448838","article-title":"Autoimmune encephalitis in children","volume":"27","author":"Armangue","year":"2012","journal-title":"J\u00a0Child Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurology(R) neuroimmunology Neuroinflamm"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000663","article-title":"Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient","volume":"7","author":"Cellucci","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI125178","article-title":"Autoimmune seizures and epilepsy","volume":"129","author":"Geis","year":"2019","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17391","article-title":"International consensus recommendations for management of New Onset Refractory Status Epilepticus (NORSE) including Febrile Infection-Related Epilepsy Syndrome (FIRES): Summary and Clinical Tools","volume":"63","author":"Wickstrom","year":"2022","journal-title":"Epilepsia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3345\/cep.2022.00346","article-title":"Moderate to severe atopic dermatitis in children: focus on systemic Th2 cytokine receptor antagonists and Janus kinase inhibitors","volume":"67","author":"Kim","year":"2024","journal-title":"Clin Exp pediatrics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24872","article-title":"Microtubule-associated protein 1B: Novel paraneoplastic biomarker","volume":"81","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/1531-8249(200003)47:3<297::AID-ANA4>3.0.CO;2-4","article-title":"New Purkinje cell antibody (PCA-2): Marker of lung cancer-related neurological autoimmunity","volume":"47","author":"Vernino","year":"2000","journal-title":"Ann Neurology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322175","article-title":"Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgG","volume":"91","author":"Jitprapaikulsan","year":"2020","journal-title":"J neurology neurosurgery Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/cdep.12439","article-title":"Capturing the complexity of autism: Applying a developmental cascades framework","volume":"16","author":"Bradshaw","year":"2022","journal-title":"Child Dev perspectives"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2020.16.4.530","article-title":"Anti-SOX1 antibodies in paraneoplastic neurological syndrome","volume":"16","author":"Sun","year":"2020","journal-title":"J Clin Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000676","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy","volume":"32","author":"Kunchok","year":"2019","journal-title":"Curr Opin Neurology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001032","article-title":"Argonaute autoantibodies as biomarkers in autoimmune neurologic diseases","volume":"8","author":"Do","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-4614-5107-5_4","article-title":"Autoantibodies to argonaute 2 (Su antigen)","volume":"768","author":"Satoh","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.328","article-title":"Paraneoplastic cerebellar degeneration with anti-Yo antibodies \u2013 a review","volume":"3","author":"Venkatraman","year":"2016","journal-title":"Ann Clin Trans Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000502958","article-title":"Atopic march: collegium internationale allergologicum update 2020","volume":"181","author":"Aw","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2011.01572.x","article-title":"SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes","volume":"125","author":"Stich","year":"2012","journal-title":"Acta Neurologica Scandinavica"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/1941874418802130","article-title":"Cerebellar ataxia with extreme photophobia associated with anti-SOX1 antibodies","volume":"9","author":"Alessandro","year":"2018","journal-title":"Neurohospitalist"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2231","article-title":"Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic kelch-like protein-11 encephalitis","volume":"77","author":"Dubey","year":"2020","journal-title":"JAMA Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2021-000236","article-title":"Coexistent anti-GFAP and anti-MOG antibodies presenting with isolated meningitis and papillitis: more support for overlapping pathophysiology","volume":"4","author":"Martin","year":"2022","journal-title":"BMJ Neurol Open"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003586","article-title":"Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies","volume":"88","author":"Do","year":"2017","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1146536","article-title":"Autoimmune encephalitis with mGluR5 antibodies: A case series from China and review of the literature","volume":"14","author":"Guo","year":"2023","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2007.03.015","article-title":"Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis","volume":"186","author":"T\u00fcz\u00fcn E","year":"2007","journal-title":"J neuroimmunology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-330707","article-title":"Anti-Argonaute antibodies as a potential biomarker in NMOSD","volume":"94","author":"Carta","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1756286420985323","DOI":"10.1177\/1756286420985323","article-title":"Paraneoplastic neurological syndromes: clinical presentations and management","volume":"14","author":"Devine","year":"2021","journal-title":"Ther Adv Neurological Disord"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1678497\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:33:58Z","timestamp":1771918438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1678497\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2025.1678497"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1678497","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"article-number":"1678497"}}